Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Microsoft’s Face Check: The cutting-edge technology that’s shaking up the world of identity verification! In a bold leap forward in digital security, Microsoft has fully launched Face Check, an innovative identity verification… byPallavi MadhirajuAugust 13, 2024